Skip to content

VGXI adds RNA suite to tap growing cell and gene therapy market

VGXI has set up an RNA pilot production suite at its facility in Woodlands, Texas citing growing demand from gene therapy developers.
The GMP-grade mRNA manufacturing unit will support customer projects from initial plasmid construction through linearization, in vitro translation, mRNA purification, and comprehensive quality control testing according to VGXI.

VGXI plans to launch clinical grade mRNA manufacturing services next year.
Methodical expansion

The pilot plant was set up as part of the VGXI licensing deal with the Houston Methodist Research Institute.

The CDMO said it will continue to work with the Institute’s RNACore group – a research team focused on RNA synthesis – to set up a large-scale GMP mRNA production facility.

Read More